LifeWatch AG

EANS-Adhoc: LifeWatch Announces the World's First iPad ECG Report Viewers

-------------------------------------------------------------------------------- ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. -------------------------------------------------------------------------------- New Products/LifeWatch AG 11.05.2010 Chicago, IL / USA May 11 2010 -LifeWatch Services, Inc., a subsidiary of LifeWatch AG (SIX Swiss Exchange: LIFE), will announce the launch of their remote ECG report TeleViewer application for the Apple iPad. The iPad application integrates with and enhances the advanced reporting and workflow management capabilities present in their web based applications for all product offerings. The LifeWatch TeleViewer will also be part of their newly announced series of remote patient monitoring service packages called TeleClinics. The iPad's ease-of-use, portability, convenience and multi-touch capabilities are well suited to the timely review of patient remote monitoring reports that provide comprehensive and actionable information for Physicians. These features will help physicians increase their productivity and standard of care through a streamlined work flow and immediate access to critical patient data that enables faster diagnosis and better treatment options, and to this end, helps eliminate unnecessary and costly hospitalizations and readmissions. LifeWatch's TeleViewer can help reduce risk of error as patient care is increasingly handed off from one doctor to another. It makes keeping in touch with LifeWatch and the patient a simple and easy task. The physician benefit is increased productivity, streamlined work and data flow making more time for patient care. The TeleViewer takes advantage of the large iPad screen to produce clear and accurate viewing images of both reports and ECG strips. The new (Atrial Fibrillation) AF TeleClinic that is being announced this week at the Heart Rhythm Society meeting in Denver will be available on the TeleViewer. LifeWatch will provide iPad TeleViewers to physicians enrolled in the AF TeleClinic service. AF TeleClinic is a treatment-focused service package that provides a standard panel of monitoring tests at pre-set intervals and advanced analysis reporting tools for post- procedure AF patients. LifeWatch is focusing on ability to deliver the remote patient monitoring data to physicians and clinicians anytime, anywhere. "Bringing the iPad's innovative multi-touch apps and the e-book reader functionality to the medical community makes it perfect for enabling physicians to review and read reports on their patients being monitored remotely", stated Brent Cohen, CEO ,LifeWatch AG." Other versions of the TeleClinic using the TeleViewer will be launched in the near future, including TeleClinics for Stroke, Syncope and Obstructive Sleep Apnea management." About LifeWatch AG: LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is also introducing a new program for Home SleepTesting of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch. For additional information, please visit {www.lifewatch.com}[HYPERLINK: http://www.lifewatch.com] and {www.nitewatchservices.com}[HYPERLINK: http://www.nitewatchservices.com] Sign-up for customized E-mail alerts and documentation requests is available at http://production.investis.com/lifewatch/alert-service/ This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, business strategy and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short term and long term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER. Apple is a trademark of Apple Inc., registered in the U.S. and other countries. iPad is a trademark of Apple Inc. end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: LifeWatch AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch Tel +1 847 813 4299 | Fax +1 847 813 24 48 | Email {wkim@lifewatch.com}[HYPERLINK: mailto:wkim@lifewatch.com] Sensus Investor and Public Relations GmbH, Zürich: Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch Branche: Healthcare Providers ISIN: CH0012815459 WKN: 1281545 Index: SPI, SPIEX Börsen: Frankfurt / Open Market / XETRA SIX Swiss Exchange / Hauptsegment Berlin / free trade

Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: